Synopsis

Source of validity: Scientific
Rating (out of 5): 2

Bifidobacterium bifidum is one of several probiotic strains investigated for their potential role in supporting or treating Inflammatory Bowel Disorders (IBD), including Crohn’s disease and ulcerative colitis. The scientific rationale for its use is based on its ability to modulate the gut microbiota, enhance mucosal barrier function, and exert immunomodulatory effects, such as reducing pro-inflammatory cytokines. Several small-scale clinical studies and animal experiments have demonstrated that B. bifidum may help restore microbial balance in the gut and decrease intestinal inflammation, key issues in IBD pathogenesis. For example, some trials have shown improvements in IBD symptoms and mucosal healing when B. bifidum is administered as part of a multi-strain probiotic formula (such as VSL#3), though evidence for B. bifidum as a single agent is more limited.

Despite these encouraging findings, current human clinical evidence is modest in both quality and quantity. Most studies use combinations of probiotic strains rather than B. bifidum alone, making it difficult to attribute effects specifically to this species. Meta-analyses of probiotics for IBD suggest a potential benefit, particularly in ulcerative colitis, but results are inconsistent, and guidelines do not yet universally recommend probiotics for IBD management. Overall, while the use of B. bifidum is scientifically plausible and supported by preliminary studies, robust, large-scale randomized controlled trials are still needed. The current evidence base is best described as promising but not definitive.

More about Bifidobacterium bifidum
More about Inflammatory Bowel Disorders

Other ingredients used for Inflammatory Bowel Disorders

Other health conditions supported by Bifidobacterium bifidum

Products containing Bifidobacterium bifidum

Nature's Sunshine Eleven Elevated (NutriBiome)
Nature's Sunshine Probiotic Eleven
Nature's Sunshine Sunshine Heroes Probiotic Power